Virtual care is here to stay. At the Fierce Healthcare Payer Summit, Eric Weil, MD FACP, will discuss how can health plans get ahead of the curve. Learn more: bit.ly/44X1AqV

Aligning on treatment measurements in behavioral health can drive improvements in care, cost, and collaboration between patients, providers, and plans. Learn more about Evernorth’s new measurement-based care program: bit.ly/3tspmOh

With 25 years of meeting patients in their homes, Evernorth integrated, in-home primary care strategically connects solutions to support polychronic patients and save money for plans. Guaranteed. Learn more: bit.ly/3FagmQM

Gene therapies have the potential to treat and cure debilitating diseases – and the pipeline continues to grow. Plan sponsors should prepare now by first understanding the basics of gene therapies. Learn more here: bit.ly/402T0pz

As chronic conditions increase, physician shortages and a lack of access create gaps in care. Plan sponsors can leverage pharmacists to close those gaps. Learn more: bit.ly/3SkvhPU

Health care spend could reach $7.2 trillion by 2031. 85% of that is due to polychronic patients. Using a value-based approach can guarantee lower costs for plans, while improving quality of life for patients: bit.ly/46pc3gk

Gene modification and cellular therapies leverage gene-altering technology to treat and potentially cure a wide range of rare conditions. Ensuring access for eligible patients will become a more critical consideration for plan sponsors. Learn more: bit.ly/3Qm1QeR

At Evernorth, we make the treatment of health care’s most complex conditions more accessible to improve costs and outcomes. Learn more: bit.ly/3S2kBW4

Dr. Calie Santana, senior medical principal for innovation at Evernorth, spoke at the Population Health Colloquium about partnering with health plans and employers to solve the social determinants of health which influence 80% of the health care outcome. bit.ly/3QBMbqG

Despite increases in list prices for medications, Express Scripts by Evernorth helped members save money at the pharmacy and lowered the cost of diabetes care in 2022. Dive into the research here: evernorth.com/articles/numbe…

Rebates are often blamed for rising prices of long-acting insulin medicines which treat type 1 and type 2 diabetes. Yet new insights from Express Scripts, Evernorth’s PBM, found the greatest price increases occurred when rebates were at their lowest. evernorth.com/articles/resea…

Health care spend could reach $7.2 trillion by 2031. 85% of that is due to polychronic patients. Using a value-based approach can guarantee lower costs for plans, while improving quality of life for patients. Learn more: bit.ly/46pc3gk

At Evernorth, we drive organizations, businesses, and people forward by making the right treatments more accessible. Learn more: bit.ly/3S2kBW4

We see vast opportunities to enable meaningful change in the health care industry. At Reuters Total Health, Evernorth’s Eric Palmer and Eva Borden shared how we’re pushing health care forward. Click here to read their insights: bit.ly/3TvltTT

Accredo specialty pharmacy supports patients with their medications and much more. Meet some of the social workers, dietitians, and patient care advocates making a difference every day. bit.ly/3RSYOQ4

We sat down with our Director of Care Solutions Oliver Dittus to talk about how Evernorth’s population health managers work with health plans to gain insights about members to help them better coordinate care. Read the full interview here: bit.ly/3TUmUvu

2023 was a year of innovation and groundbreaking advancements for Express Scripts by Evernorth. See how we helped 100 million members get the medicines they need, when they need them, while driving greater medication affordability. bit.ly/3tEq9wp

It’s not too late to get vaccinated against the flu. Data from the Evernorth Research Institute suggests that serious cases are on the rise, especially among children under 18, Medicaid recipients, and people living in the South. Learn more: evernorth.com/articles/presc…

The answer to recruiting more patients for local clinical drug trials is simple. Put them at the center. Evernorth’s Gene Jay, head of clinical trial solutions, and other experts shared how to enhance recruitment in a recent panel discussion. Read more: evernorth.com/articles/enhan…

It’s almost time for #EvernorthOutcomes 2024! We can’t wait to kick off three days of thought-provoking sessions on the topics that matter most to plans, sponsors, and patients.